Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

NCT05417308 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

NCT00958750 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

NCT07012486 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

NCT03315689 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

NCT07205159 ·Status: RECRUITING ·Phase: PHASE1

Clinical Trial in Females With Female Pattern Hair Loss

NCT01145625 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Effects and Tolerance of the RV4986A Lotion in Men With AGA After Hair Transplant

NCT06576492 ·Status: COMPLETED ·Phase: NA

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

NCT05865041 ·Status: RECRUITING ·Phase: PHASE2

A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

NCT01904721 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

NCT07200128 ·Status: COMPLETED

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

NCT01286649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

NCT02018042 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

NCT01325337 ·Status: COMPLETED ·Phase: PHASE2

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

NCT03594227 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata

NCT05910138 ·Status: UNKNOWN ·Phase: NA

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02812342 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Secukinumab for the Treatment of Alopecia Areata

NCT02599129 ·Status: TERMINATED ·Phase: PHASE2

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

NCT02483195 ·Status: WITHDRAWN ·Phase: PHASE4

Clinical Trial in Females for Female Pattern Hair Loss

NCT01226459 ·Status: COMPLETED ·Phase: PHASE3

Minoxidil Response Testing in Females With Female Pattern Hair Loss

NCT02206802 ·Status: COMPLETED

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

NCT07101471 ·Status: COMPLETED

Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

NCT01655108 ·Status: UNKNOWN ·Phase: PHASE3

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

NCT06399783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4